MedPath

Philippines FDA Approvals

FDA Philippines approved pharmaceutical products and drug approvals

Food and Drug Administration of the Philippines
Philippines
30,876 Approvals
Showing 30841 to 30860 of 30,876 approvalsPage 1543 of 1544

Oprazid

Issued: Apr 1, 2022

Benadrex

Issued: Apr 1, 2022

Capnorm-500

Issued: Apr 1, 2022

Quizole

Issued: Apr 1, 2022

Saphticone-OD

Issued: Apr 1, 2022

None

Issued: Apr 1, 2022

Urgiso

Issued: Apr 1, 2022

Nutrilon SN 5

Issued: Apr 1, 2022

Solclav

Issued: Apr 1, 2022

Paraxam

Issued: Apr 1, 2022

Gastrosil

Issued: Apr 1, 2022

Calbic

Issued: Apr 1, 2022

VASCOR

Issued: Apr 1, 2022
Amherst Laboratories, Inc.

Vsiqq

Issued: Apr 1, 2022
Novartis Healthcare Philippines, Inc.

Triloupe

Issued: Apr 1, 2022

None

Issued: Apr 1, 2022

Alzor

Issued: Apr 1, 2022

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.